The Patents
The chemotherapeutic galvanostat/potentiostat (CGP) is a patent protected invention in the United States of America (U.S. patent no.: 11,198,943) and Canada (CA patent no.: 3,035,406), with patent cooperation treaty (PCT) disclosure, effectively making the CGP and it's underlying technologies hereby unpatentable in every country on Earth, post 2017 (figure 1).
Figure 1. The World of Innovative Potential. White: Patent Zone; Green: Disclosure Zone.
Expiry: 2038
Figure 1 has four (4) essential implications and effects, namely:
-
Individuals, public governments, and companies in unpatented nations do not have: the ability to gain domestic patent protection for CGP production, processes, and or use because of previous disclosure (i.e.: it's not inventable by you because it was already invented by me; and, that publication, or disclosure, is now Nationally and legally recognized across all PCT-member Nations); which means:
-
The legal duties and responsibilities for local-nation CGP technology, knowledge, application, and preservation are legally bound to those entities entreatied by the PCT, and do not have National patents issued; additionally: those entities can not monopolize CGP technology within their nations; and,
-
Those States that do have National patents issued to Innovative Potential (i.e.: The United States, and Canada) are bound to Innovative Potential as a type of centralizing government for the purposes of the patent(s) (i.e.: these two (2) governments (Canada and the U.S.) are internally and legally obligated to participate cooperatively and financially with Innovative Potential, at the exclusion of all others within their Nations as applicable, by virtue of the disqualification and exclusion of the rights of the other citizens that the respective National patent laws bestow upon Innovative Potential, and Innovative Potential alone, and more so because their lives and the lives of their citizenry shall come to depend on EAC and CGP technologies. The perpetuating failures of both of these contracting States to participate directly with Innovative Potential as properly functioning Nations has created and grown The Situation); and,
-
The entire Disclosure Zone is one gigantic free market, but not the Patent Zone: the Patent Zone is a regulated or controlled market (i.e.: monopolized; i.e.: Innovative Potential).
